Soft tissue sarcoma is an umbrella term which encompasses over 60 histological tumour types. Approximately 15% of soft tissue sarcomas arise in the retroperitoneum. This complex group of tumours poses unique management challenges due to their often large size, histological heterogeneity and complexity of anatomical relationships. This review discusses the management of retroperitoneal tumours including the need for preoperative diagnosis, the evidence for neoadjuvant radiotherapy, the role of multivisceral resection and the importance of a multidisciplinary team approach
The location of soft tissue sarcoma (STS) in the retroperitoneal space (about 15% of all STS) is a s...
Surgery is the key treatment in retroperitoneal sarcoma (RPS), as completeness of resection is the m...
Retroperitoneal sarcomas (RPS) are rare tumours that typically present late and carry a poor prognos...
Aims: Successful surgical treatment of patients with retroperitoneal soft tissue sarcoma (RSTS) is b...
Aims: Successful surgical treatment of patients with retroperitoneal soft tissue sarcoma (RSTS) is b...
Retroperitoneal sarcomas (RPS) are rare cancers whose management can be challenging due to various p...
Although retroperitoneal sarcomas are rare tumours, they can be encountered by a wide variety of cli...
Retroperitoneal soft tissue sarcoma (RPS) is a rare and heterogenous disease for which surgery is th...
Purpose. In the clinical work-up of a retroperitoneal mass, the diagnosis of soft tissue sarcoma is ...
Retroperitoneal sarcomas are a rare group of malignant soft tissue tumors with a generally poor prog...
BACKGROUND Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare tumors of ...
Retroperitoneal tumors are extremely rare. More than 70% of primary retroperitoneal soft tissue tumo...
Abdominal and retroperitoneal sarcomas (RPS) represent approximately 25-30% of all soft tissue sarco...
AIMS AND BACKGROUND: Retroperitoneal sarcomas are a rare group of malignant soft tissue tumors with ...
Purpose of review Retroperitoneal sarcomas are rare tumors and with complex treatment. In this manus...
The location of soft tissue sarcoma (STS) in the retroperitoneal space (about 15% of all STS) is a s...
Surgery is the key treatment in retroperitoneal sarcoma (RPS), as completeness of resection is the m...
Retroperitoneal sarcomas (RPS) are rare tumours that typically present late and carry a poor prognos...
Aims: Successful surgical treatment of patients with retroperitoneal soft tissue sarcoma (RSTS) is b...
Aims: Successful surgical treatment of patients with retroperitoneal soft tissue sarcoma (RSTS) is b...
Retroperitoneal sarcomas (RPS) are rare cancers whose management can be challenging due to various p...
Although retroperitoneal sarcomas are rare tumours, they can be encountered by a wide variety of cli...
Retroperitoneal soft tissue sarcoma (RPS) is a rare and heterogenous disease for which surgery is th...
Purpose. In the clinical work-up of a retroperitoneal mass, the diagnosis of soft tissue sarcoma is ...
Retroperitoneal sarcomas are a rare group of malignant soft tissue tumors with a generally poor prog...
BACKGROUND Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare tumors of ...
Retroperitoneal tumors are extremely rare. More than 70% of primary retroperitoneal soft tissue tumo...
Abdominal and retroperitoneal sarcomas (RPS) represent approximately 25-30% of all soft tissue sarco...
AIMS AND BACKGROUND: Retroperitoneal sarcomas are a rare group of malignant soft tissue tumors with ...
Purpose of review Retroperitoneal sarcomas are rare tumors and with complex treatment. In this manus...
The location of soft tissue sarcoma (STS) in the retroperitoneal space (about 15% of all STS) is a s...
Surgery is the key treatment in retroperitoneal sarcoma (RPS), as completeness of resection is the m...
Retroperitoneal sarcomas (RPS) are rare tumours that typically present late and carry a poor prognos...